ahuebner@guardanthealth.com

STAT reporter Nicholas St. Fleur talks with Guardant Health co-CEO Helmy Eltoukhy about patient access to precision oncology testing.
July 10, 2024

Blood Tests for Cancer Patients Save Lives. Access Remains an Issue.

Guardant signage outside company headquarters
June 11, 2024

FDA Advisory Committee Strongly Recommends Approval For Guardant Health Blood Test For Colorectal Cancer

Panel recommends approval of Shield as primary non-invasive screening option in adults aged 45 and older at average risk for the disease

Guardant Health male lab technician
May 30, 2024

TIME100 Most Influential Companies 2024: Guardant Health

Shield blood test box.
May 23, 2024

F.D.A. Panel Endorses Safety of Colon-Cancer Blood Test

Clinician and patient discussing with a tablet.
May 21, 2024

Let’s Enter a New Era of Options for Colorectal Cancer Screening

Colorectal cancer is the second-leading cause of cancer death in the United States. Rates are rising in younger – and middle-aged individuals.

Blood vials on a piece of paper.
May 13, 2024

Guardant Health Preps for FDA Advisory Panel Review of its Blood-Based Colorectal Cancer Screening Test

Female lab tech.
April 17, 2024

Leveling the Health Care Playing Field through Emerging Technology

Image of a lung and a virus.
April 4, 2024

Study Reveals New Liquid Biopsy Test Could Benefit Thousands of Lung Cancer Patients

Fast company logo. Most innovative companies of 2024.
March 19, 2024

Meet the Diagnostics Company Helping Find Cancer and Choose the Right Treatment

Guardant lab technician at work
March 14, 2024

Q&A with Guardant Health about Blood Tests for CRC Screening